Approximately 60% of healthy term neonates have clinical jaundice in the first week after birth [1] [2] [3] [4] . About 0.02-0.16% of these infants develop extreme hyperbilirubinemia (e"428 mmol/L) 1,5 . Treatment is usually given for the prevention of bilirubin encephalopathy 4 . When the bilirubin is rising continuously, instead of declining in spite of phototherapy, to the level that kernicterus is considered a threat, then exchange transfusion (ET) is considered. Although ET is considered to be a safe procedure, it is not risk free, and mortality rates vary from 0.5 to 3.3% 6-9 . The level of bilirubin concentration at which ET should be indicated remains the subject of disagreement, since the incidence of bilirubin encephalopathy also depends on other variables such as gestational age, the presence or absence of haemolysis and the newborn's clinical status. Current recommendations for performing ET are based on balance between the risks of encephalopathy and the adverse events related to the procedure 10 . This study was undertaken with the objectives of determination of the indication of exchange transfusion and also to 
Materials and methods
The medical records of infants < 28 days old who required ET due to neonatal jaundice in Special Care Baby Unit (SCABU), BIRDEM hospital from January 2009 to April 2010 were retrospectively reviewed. ET procedures were performed by the medical team of the unit. Infants' heart rate and oxygen saturation were monitored during the procedure. The umbilical vein was the only access employed for the procedure and the volume of blood used in the exchange corresponded to twice the patient's blood volume. In all cases, whole blood was used for the procedure within 12 hours after collection. All patients were given to phototherapy before and after the procedure. Serum bilirubin , complete hemogram including reticulocyte count, blood grouping (ABO and Rh) for mother and baby and direct Coomb's test report were collected for all babies. The morbidity and mortality caused by each ET which occurred within 3 days of the procedure was defined as complications. All episodes of complication were recorded. Statistical analysis was carried out using SPSS (version 12.0).
Results
Exchange transfusion was done in 30 neonates during the study period. Among them 13 (43.33%) were male and 17(56.67%) were female; 63% were inborn and 37% were outborn. Mean gestational age of neonates was 33.33 ± 3.67 wks and mean birth weight was 1725 ±400 gm. Twenty two (73.34%) baby were preterm and 8 (26.66%) baby were term ( Table-I ). In this study 46.7% were infant of diabetic mother, 10% neonate had respiratory distress syndrome and 6.66% had birth asphyxia (Table-II) . 
Discussion
Exchange blood transfusion remains the gold standard for effective treatment of neonatal hyperbilirubinaemia. Although exchange transfusion rate was progressively declining over the years, it is still required in up to 7% of neonates admitted to nurseries 11 . This reduction in the number of exchange transfusion may be due to the development of anti-Rh globin for Rh-negative mothers and the widespread use of phototherapy for neonatal jaundice 12, 13 . In this study, causes of exchange transfusion were unidentified in 15 (50%) cases. Infant of diabetic mother (46.7%), prematurity (73.3%), respiratory distress syndrome (8.57%) and birth asphyxia (5.7%) were risk factors for hyperbilirubinaemia needed ET in this group. Narag A et al analyzed 501 cases of neonatal jaundice and they found that in 52% cases no cause for exchange transfusion was identified 14 . Exchange transfusion was done due to ABO incompatibility in 9 (30%) cases, which was similar to the findings in some other series. Dikshit and Sanpavat reported that ABO haemolytic disease of newborns was the most common cause of ET in neonates (35.9% and 21.3%, respectively) 15, 16 . Multiple exchange transfusion was required in 10% of our neonates. This is similar to findings of AbuEkteish et al 17 , but is lower than Dikshit SK study 15 .
Despite improvement in neonatal intensive care in the past two decades, exchange transfusion remains a high-risk procedure. One (3.3%) of the 30 patients in this study died of complications probably attributable to exchange transfusion. This neonate was extremely premature (26wks) and incredibly low birth weight (650mg), and developed septicaemia and electrolyte imbalance following ET. 21 .
In conclusion, though sample size was small, this report indicates that ABO incompatibility was the commonest identified cause of exchange transfusion. Adverse events remain common after exchange transfusion. Most of the complications were transient and improved with treatment. Mortality rate was low in this study. So it is still a good modality of treatment for severe neonatal jaundice.
